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ABSTRACT 
Background: In surgical patients, decreasing the fresh gas flow rate in anes- 
thesia may minimize costs, reduce environmental pollution, and preserve heat 
and humidity in the respiratory system. 
Objective: The aim of this study was to investigate the effects of 3 low-flow 
desflurane rates on perioperative hemodynamic stability, end-tidal desflurane 
concentration, emergence and recovery characteristics, and agent consumption. 
Methods: This open-label, prospective study was conducted at the Depart- 
ment of Anesthesiology and Reanimation, University of Gaziantep, Gaziantep, 
Turkey. Nonpremedicated adult patients scheduled to undergo surgery (ure- 
terolithotomy, cholecystectomy, pyelolithotomy, or thyroidectomy) were en- 
rolled. Patients were anesthetized with propofol and fentanyl and intubated 
after neuromuscular blockade with vecuronium. Patients were randomly allocat- 
ed to 1 of 3 groups according to the fresh gas flow rate: medium flow (2 L/min), 
low flow (1 L/rain), and minimal flow (0.5 L/rain). Intraoperative f ntanyl vol- 
ume was recorded. Heart rate, mean arterial pressure, and end-tidal desflurane 
concentration were recorded before (baseline) and after anesthesia induction; 
immediately before incision; and 5, 10, 15, 30, 45, and 60 minutes after incision. 
Emergence time and desflurane consumption after extubation were recorded. 
AIdrete scores were recorded at 5, 15, and 30 minutes after extubation. 
Results: Ninety patients (46 women, 44 men; mean [SD] age, 39.74 [13.73] 
years; 30 patients per treatment group) participated in the study. Means of 
hemodynamic parameters, intraoperative volume of fentanyl, end-tidal desflu- 
rane concentration, emergence time, and Aidrete score were statistically simi- 
lar between the 3 groups. Mean (SD) desflurane consumption was significant- 
ly higher in the medium-flow group compared with the low- and minimal-flow 
groups (110.43 [28.18] g vs 98.40 [23.62] g and 79.80 [17.54] g, respectively; 
both, P < 0.01). Mean (SD) desflurane consumption was also significantly higher 
in the low-flow group compared with the minimal-flow group (P < 0.01). 
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Condusion: The results of the present study in adult surgical patients ug- 
gest that desflurane may be used in low-flow anesthesia, even with the mini- 
mal fresh gas flow rate. (CurrRes Ther Clin Exp. 2005;66:4-12) Copyright © 2005 
Excerpta Medica, Inc. 
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INTRODUCTION 
Low-flow anesthesia results in at least 50% of exhaled air being returned to 
the lungs after CO 2 absorption. 1 This degree of "rebreathing" can be achieved 
if the fresh gas flow rate is reduced to -2 L/min. 2 To standardize the terminol- 
ogy for breathing circuits, Baker s suggested the following modification of 
Simionescu's classification 4 of fresh gas flow rates in clinical practice: high 
flow (>2-4 L/rain), medium flow (>1-2 L/rain), low flow (>0.5-1 L/rain), and 
minimal flow (<0.5 L/min). Low-flow anesthesia may minimize the cost of the 
anesthetic, reduce environmental pollution, and preserve heat and humidity 
in the respiratory system, s G 
Desflurane is the least soluble of the inhaled anesthetic agents, with a blood/ 
gas partition coefficient of 0.42. Its pharmacokinetic properties and rapid me- 
tabolism make it effective in low-flow systems. 7 A MEDLINE search (key 
terms: low flow and desflurane; years: 1990-2004) identified some studies com- 
paring the effects of desflurane with those of other inhaled anesthetics. ~-l° 
However, studies comparing the effects of differing desflurane flow rates in 
low-flow anesthesia were unavailable. 
The aim of this study was to investigate the effects of 3 differing flow rates 
on perioperative hemodynamic stability, end-tidal desflurane concentration, 
emergence and recovery characteristics, and agent consumption in low-flow 
desflurane anesthesia. 
PATIENTS AND METHODS 
For this open-label, prospective study, approval of the protocol was obtained 
from the institutional ethics committee at the Department of Anesthesiology 
and Reanimation, University of Gaziantep, Gaziantep, Turkey. Written informed 
consent was obtained from each patient. 
Indusion and Exclusion Criteria 
Patients aged 18 to 65 years with American Society of Anesthesiologists 
physical status I or II (ie, healthy) and scheduled to undergo surgery (ure- 
terolithotomy, cholecystectomy, pyelolithotomy, or thyroidectomy) with 
general anesthesia (GA) were included. Patients with alcoholism or obesity 
or a history of hepatic, renal, or cardiovascular disease were excluded from 
the study. Pregnant, possibly pregnant, or breast-feeding women were also 
excluded. 
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Induction of Anesthesia 
Patients received no premedication. After preoxygenation, GA was induced 
with propofol 2.0 to 2.5 mg/kg IV and [entanyl 1 to 3 pg/kg IV. Neuromuscular 
blockade was achieved using vecuronium 0.1 mg/kg IV, and intermittent posi- 
tive pressure ventilation was applied using an anesthesia machine (Cato 
Anaesthetic Workstation, Dr~igerwerk AG, LObeck, Germany). End-tidal CO 2 ten- 
sion (PETCO2) was monitored and maintained in the range of 30 to 40 mm Hg 
during surgery. The desflurane* vaporizer (Devapor, Dr~igerwerk AG) concen- 
tration setting was adjusted to 4% to 6% after endotracheal intubation, and a 
high-flow (6 L/min) denitrogenization phase was applied for 6 to 8 minutes to 
reach a sufficient level of anesthesia. 
Using a computer-generated able of random numbers, patients were allocated 
to 1 of 3 groups according to the fresh gas flow rate (medium, low, or minimal). 
Before each administration ofanesthetic, the absorber canister was filled with fresh 
soda lime (Ber-kim Ltd., Istanbul, Turkey). In all 3 groups, the desflurane vaporizer 
concentration setting was adjusted to between 3% and 5%. In the medium-flow 
group, the fresh gas flow rate was 2 L/min (1 L/min 02 + 1 L/min N20 + desflurane); 
in the low-flow group, 1 L/min (0.5 L/min 02 + 0.5 L/min N20 + desflurane); and 
in the minimal-flow group, 0.5 L/rain (0.3 L/min 02 + 0.2 L/rain N20 + desflurane). 
Evaluations of Effects of Flow Rates 
Heart rate (HR), mean arterial pressure (MAP), and end-tidal desflurane con- 
centration were Monitored and noted before (baseline) and after GA induction; 
immediately before incision; and 5, 10, 15, 30, 45, and 60 minutes after incision 
(PM 8040 Monitor, Dr~gerwerk AG). Inspired and expired 02 and N20 values 
were also continuously measured. Additional doses of fentanyl 1 pg/kg IV were 
administered if MAP increased by >20% of baseline, and a similar decrease in 
MAP was treated with ephedrine 5 to 10 mg IV. The fresh gas flow rate was 
increased to high (6 L/rain) 10 to 15 minutes before closure in all 3 groups. Af- 
ter closure, residual neuromuscular blockade was antagonized using atropine 
0.02 mg/kg IV and neostigmine 0.06 mg/kg IV. 
After opening their eyes on command, patients were extubated. Emergence 
time (open eyes, extubation, and response to verbal commands) and desflurane 
consumption (by weighing the vaporizer) were measured. AIdrete scores 11 
(scale: 0 = anesthetized to 10 = full recovery; _>9 is needed for full recovery) 
(Table I) were assessed and noted at 5, 15, and 30 minutes after extubation. 
Patients having AIdrete scores >9 were sent to the postanesthetic care unit and 
patients with Aidrete scores <9 were given 100% 02 until the score became _>9. 
The flow rate was to be increased to 6 L/min in patients experiencing _>1 ad- 
verse effect (eg, hypertension, tachycardia, hypotension, increased PETCO 2, 
decreased peripheral arterial oxygen saturation, bradycardia). 
*Trademark: Suprane ® (Baxter International, Inc., Guaynabo, Puerto Rico). 
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Table I. Modified Aldrete scale. 
Criterion Score 
Oxygenation 
SpO 2 >92% on room air 2 
SpO 2 9096-92% on 02 I 
SpO 2 <90% on 02 0 
Respiration 
Breathes deeply and coughs freely 2 
Dyspneic, shallow or limited breathing I 
Apnea 0 
MAP 
±20 mm Hg of normal 2 
±21-50 mm Hg of normal I 
>±50 mm Hg of normal 0 
Consciousness 
Fully awake 2 
Arousable on calling 1 
Nonresponsive 0 
Activity 
Moves all extremities 2 
Moves 2 extremities 1 
No movement 0 
Total score* 
SpO~ = pulse oximetry saturation; MAP = mean arterial pressure. 
*Sca~ 0 = anesthetized to 10 = full recovery; total score ~9 is needed for full recovery. 
Modified with permission. N 
Statist ical Analysis 
Statistical analyses were performed using SPSS version 11.0 (SPSS Inc., 
Chicago, Illinois). One-way analysis o[ variance and post hoc multiple compar- 
isons (Tukey test for homogeneous groups and Tamhane test [or nonhomoge- 
neous groups) were used to compare the between-group results. P < 0.05 was 
considered statistically significant. 
RESULTS 
Ninety patients (46 women, 44 men; mean [SD] age, 39.74 [ 13.73] years; 30 patients 
per treatment group) participated in the study (Table II). None of the patients 
were withdrawn from the study alter randomization. 
Mean (SD) intraoperative use oI Ientanyl was similar between the 3 groups: 
medium flow, 185.00 (41.83) pg; low flow, 181.66 (48.21) pg; and minimal flow, 
181.66 (30.74) pg (Table IF). Mean (SD) desflurane consumption was significant- 
7 
CURRENT THERAPEUTIC RESEARCH 
Table II. Baseline demographic and clinical characteristics of the study patients 
(N = 90). 
Medium Flow Low Flow Minimal Flow 
Characteristic (n = 30) (n = 30) (n = 30) 
Age, mean (SD), y 39.96 (I 4.49) 38.46 (15.05) 40.80 (I 1.63) 
Sex, no. (%) 
Female 14 (46.7) 16 (53.3) 
Male 1 6 (53.3) 14 (46.7) 
Body weight, mean (SD), kg 74.50 (9.65) 70.30 (9.1 8) 
Height, mean (SD), cm 167.76 (7.01) 1 66.46 (7.78) 
ASA physical status,* no. (%) 
I 22 (73.3) 21 (70.0) 
II 8 (26.7) 9 (30.0) 
Surgical procedure, 
no. (%) of patients 
Ureterolithotomy 14 (46.7) 13 (43.3) 
Cholecystectomy 8 (26.7) 8 (26.7) 
Pyelolithotomy 3 (10.0) 5 (16.7) 
Thyroidectomy 5 (16.7) 4 (13.3) 
Duration of anesthesia, 
mean (SD), rain 134.03 (44.82) 140.50 (50.02) 
Duration of surgery, 
mean (SD), rain 118.86 (42.87) 127.43 (49.69) 
Total fentanyl dose, 
mean (SD), IJg 181.66 (48.21) 181.66 (30.74) 
Desflurane consumption, 









5 (I 6.7) 




110.43 (28.18) n 
ASA = American Society of Anesthesiologists. 
*ASA physical status I and II = healthy. 
tp < 0.01 versus low-flow group. 
~P < 0.01 versus minimal-flow group. 
ly higher in the medium-flow group compared with the low- and minimal-flow 
groups (110.43 [28.18] g vs 98.40 [23.62] g and 79.80 [17.54] g, respectively; 
both, P < 0.05). Mean (SD) desflurane consumption was also significantly high- 
er in the low-flow group compared with the minimal-flow group (P < 0.01). 
No statistically significant differences in perioperative HR, MAP, or end-tidal 
desflurane concentration were found between the 3 groups. HR and MAP remained 
within 20% of baseline values in all 3 groups (Table III). Mean emergence times and 
modified Aldrete scores were statistically similar between the 3 groups (Table IV). 
No adverse ffects related to the low-flow anesthesia were observed in any group. 
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Table IV. Mean (SD)emergence times and modified Aldrete scores 11 in patients under- 
going low-flow desflurane anesthesia (N = 90).* 
Medium Flow Low Flow Minimal Flow 
Time (n = 30) (n = 30) (n = 30) 
Open eyes, min 7.1 6 (3.01) 6.00 (2.79) 6.03 (2.57) 
Extubation, min 7.96 (3.35) 6.70 (3.03) 6.50 (2.28) 
Response to verbal 
commands, min 9.76 (3.26) 8.23 (2.84) 8.46 (2.95) 
Aldrete score 
5 min 8.63 (0.61) 8.50 (0.62) 8.56 (0.67) 
15 min 9.46 (0.57) 9.63 (0.49) 9.53 (0.50) 
30 min 9.93 (0.25) 9.90 (0.30) 9.93 (0.25) 
*No significant between-group differences were found. 
DISCUSSION 
The advantages of low-flow anesthesia are reduced anesthetic gas consump- 
tion, decreased atmospheric pollution with inhaled anesthetics, preserved heat 
and humidity in the respiratory system, and significantly reduced costs, s In the 
present study, the different desflurane flow rates were not associated with dif- 
ferences in HR or MAP. Although no studies comparing the differing flow rates of 
desflurane are available in the literature, some studies a-l° have compared the 
hemodynamic effects of desflurane with those of some other gases. Bennett et 
al ~ compared the hemodynamic effects of desflurane and isoflurane in high-flow 
anesthesia nd reported that desflurane controlled hemodynamic alterations 
more rapidly than isoflurane. Dupont et al a reported similar HR, MAP, and oxy- 
gen saturation values throughout anesthesia with desflurane, isoflurane, and 
sevoflurane. Although HR and MAP might be expected to be increased in low- 
flow anesthesia, Ebert and Arain 1° reported perioperative hemodynamic stabili- 
ty with desflurane, sevoflurane, and propofol. In addition, we found that hemo- 
dynamic parameters could be maintained within the physiologic range with 
low-flow desflurane anesthesia, even with minimal fresh gas flow rates. 
Juvin et a112 reported that desflurane provides rapid emergence from anesthe- 
sia. This finding was similar to those in some other studies. 13,14 In the study by 
Juvin et al, 12 the emergence times from the end of administration f the study 
drug to extubation and eye opening were reported to be significantly decreased 
when desflurane was used versus propo[ol or isoflurane (mean [SD] extubation 
times: 6.86 [3.0], 13.1 [8.9], and 9.9 [6.5] minutes, respectively [both, P < 0.05]; 
mean [SD] eye opening times: 5.6 [3.4], 11.5 [8.4], and 11.9 [7.6] minutes, respec- 
tively [both, P < 0.03]). Based on our MEDUNE search, the present study was the 
first to compare mergence time in low-flow anesthesia with differing desflurane 
flow rates. We did not find any statistically significant differences in emergence 
times or Aidrete scores between the 3 groups. Fentanyi consumption adjacent to 
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desflurane was statistically similar between all 3 groups, suggesting that a de- 
crease in desflurane flow rate does not change the depth of anesthesia or the 
emergence time, making low flow rates preferable to high flow rates when other 
factors (eg, consumption)  are considered. 
Inhaled anesthet ics  account  for >20% of anesthet ic  drug expendi tures  
each year  in the United States. 1~ This cost is str ict ly related to consumpt ion  
and hence to flow rates, making low-flow anesthes ia  dvantageous.  Baum 2 
reported a cons iderable  decrease  in anesthet ic  onsumpt ion  and cost  sav- 
ings resulting direct ly from decreased flow rate. In the present compar ison  of 
the effects of several  desf lurane flow rates on anesthet ic  onsumpt ion,  mini- 
mal flow rate was assoc iated with the least consumption.  
CONCLUSIONS 
In this study of differing flow rates in low-flow desflurane anesthesia in surgical 
patients, per ioperat ive hemodynamic stability and statistically unchanged end- 
tidal desflurane concentrat ions were obtained, with no negative influence on 
the recovery period. Agent consumpt ion was reduced with decreased fresh 
gas flow rates. These results suggest hat low-flow desflurane anesthesia may 
be an alternative to high-flow anesthesia in patients with American Society of 
Anesthesiologists physical status I or  II, even with the minimal flow rate. 
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